Withdrawn plasma study sought to treat severe COVID
NCT ID NCT04411602
First seen Jan 11, 2026 · Last updated May 03, 2026 · Updated 21 times
Summary
This study planned to give convalescent plasma (blood from recovered COVID-19 patients) to people in the ICU with severe COVID-19 and respiratory failure. The goal was to see if it could reduce ventilator use and deaths. However, the study was withdrawn before any participants were enrolled.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COVID are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Ascension Macomb-Oakland Hospital, Warren Campus
Warren, Michigan, 48093, United States
-
Ascension Providence Hospital, Novi Campus
Novi, Michigan, 48374, United States
-
Ascension Providence Hospital, Southfield Campus
Southfield, Michigan, 48075, United States
Conditions
Explore the condition pages connected to this study.